NEORX CORPORATION

AVICIDIN

pharmaceutical products; namely, pretargeting agents for localizing pharmaceutical active agents;

BIOSTENT

pharmaceutical products; namely, preparations for the treatment of vascular disease and trauma;

BIOSTENT

pharmaceutical products, namely preparation for the treatment of vascular disease and trauma;

CHEMOTIDE

pharmaceutical preparations for the treatment of diseases and conditions of chemokine activity;

CORNABODY

Plant-produced antibodies for pharmaceutical purposes for humans and animals;

NEORX

RESEARCH SERVICES CONCERNING INJECTABLE AGENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER;

NEORX

PHARMACEUTICAL PRODUCTS, NAMELY-CANCER IMAGING KITS CONTAINING ANTIBODIES, RADIODIAGNOSTIC COMPOUNDS, AND LINKING COMPOUNDS FOR ASSOCIATING THE RADIODIAGNOSTIC COMPOUNDS WITH THE ANTIBODIES FOR USE IN CANCER IMAGING;NEO RX;

NEORX

pharmaceutical preparations used in the treatment of cancer;

NEORX

pharmaceutical preparations used in the imaging of cancer;

NRX

N;RESEARCH SERVICES CONCERNING INJECTABLE AGENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER;THE LINING IN THE DRAWING IS A FEATURE OF THE MARK AND DOES NOT INDICATE COLOR.;

NRX

The mark consists, in part, of the letters N and RX.;pharmaceutical preparations used in the imaging of cancer;n rx;RX;The lining in the drawing is a feature of the mark and does not indicate color.;